Adapting and Adjusting: Best Practices for Utilizing Telehealth in Osteoarthritis ManagementPremiere Date: Friday, January 29, 2021
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, January 29, 2022
Note: Credit Is No Longer Available
|Jason J. Wilcox, MD
Orthopedic Surgeon, Sports Medicine
Orthopedic Physician Associates
Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 surgical centers who had to cancel their hip or knee surgery revealed that 30% would have surgery despite COVID-19 risks, 15% had no help at home, and 21% felt isolated or lonely.
COVID-19 has also led to an accelerated uptake of telehealth, and its utilization in the management of OA has shown that it is cost effective, efficacious and accurate, and has a high patient satisfaction rate. However, there are challenges to its usage, including technology literacy, implementation, inability to perform examination, and regulatory barriers, which have led to the need for education.
The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.
At the end of this CE activity, participants should be able to:
- Apply strategies to manage OA during the COVID-19 pandemic.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify strategies to management OA during the COVID-19 pandemic.
Supported by an educational grant from Pfizer Inc.
Physicians, PAs, nurse practitioners, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .25 contact hours (0.025 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to PAs: PAs may claim a maximum of .25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Wilcox reports that he is a stock shareholder (directly purchased) of Pfizer Inc.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).